Late angiographic stent thrombosis after sirolimus-eluting stent implantation

Circulation Journal

Volumn 71, Issue 2, 2007, Pages 226-228

  Takahashi, Saeko ^a   Kaneda, Hideaki ^a   Tanaka, Shinji ^b   Miyashita, Yusuke ^a   Shiono, Takaaki ^a   Taketani, Yoshio ^a   Domae, Hiroshi ^a   Matsumi, Junya ^a   Mizuno, Shingo ^b   Minami, Yoshiyasu ^a   Sugitatsu, Kazuya ^a   Saito, Shigeru ^a  

^a SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

^b Division of Cardiology   (Japan)

Author keywords

Antiplatelet therapy; Drug eluting stent; Late stent angiographic thrombosis; Sirolimus eluting stent

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; RAPAMYCIN; TICLOPIDINE;

ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; STABLE ANGINA PECTORIS; THROMBOSIS;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; SIROLIMUS; STENTS; TIME FACTORS;

EID: 33846642722     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.226     Document Type: Article

References (23)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
3. Virmani R, Kolodgie FD, Farb A, Lafont A. Drug eluting stents: Are human and animal studies comparable? Heart 2003; 89: 133-138.
4. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-1971.
5. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521.
6. Liistro F, Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001; 86: 262-264.
7. Kerner A, Gruberg L, Kapeliovich M, Grenadier E. Late stent thrombosis after implantation of a sirolimus-eluting stent. Catheter Cardiovasc Interv 2003; 60: 505-508.
8. Karvouni E, Korovesis S, Katritsis DG. Very late thrombosis after implantation of sirolimus eluting stent. Heart 2005; 91: e45.
9. Pasceri V, Pelliccia F, Cianfrocca C, Pristipino C, Santini M, Richichi G. Very late thrombosis after sirolimus-eluting stent implantation. J Cardiovasc Med (Hagerstown) 2006; 7: 438-442.
10. Feres F, Costa JR Jr, Abizaid A. Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv 2006; 68: 83-88.
11. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998; 339: 1665-1671.
12. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003; 348: 1537-1545.
13. Juergens CP, Wong AM, Leung DY, Lowe HC, Lo S, Fernandes C, et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation. Am Heart J 2004; 147: E15.
14. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, et al. Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 954-959.
15. Katayama T, Nakashima H, Takagi C, Honda Y, Suzuki S, Iwasaki Y, et al. Predictors of sub-acute stent thrombosis in acute myocardial infarction patients following primary coronary stenting with bare metal stent. Circ J 2006; 70: 151-155.
16. Takeyasu N, Watanabe S, Noguchi Y, Ishikawa K, Fumikura Y, Yamaguchi I. Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting. Circ J 2005; 69: 780-785.
17. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088-2092.
18. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
19. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113: 1108-1113.
20. Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: A meta-analysis. J Am Coll Cardiol 2005; 45: 941-946.
21. Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data). Am J Cardiol 2005; 95: 1469-1472.
22. Virmani R, Farb A, Guagliumi G, Kolodgie FD. Drug-eluting stents: Caution and concerns for long-term outcome. Coron Artery Dis 2004; 15: 313-318.
23. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, et al. Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006; 47: 175-181.